Glioblastomas are the most frequent and aggressive primary brain tumors. Current treatments invariably fail, a consequence of the pronounced heterogen…

The Elias Tillandz prize for the best scientific publication of 2024 was presented for two groundbreaking cancer studies.

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for

A blood test can detect breast cancer drug resistance, and a combination treatment improves outcomes in colorectal cancer.

Pharma group estimates Camizestrant could be worth up to $5bn of sales in its peak year

LSD1 is a histone 3 (H3) demethylase that can either repress or activate gene expression. We discover here that the so far enigmatic balance between these two activities in non-hormonal cancer cells i...